For anyone who wants real sweetness without the crash, the spike, or the guilt, Supercrose® delivers something the world has never had before: the full sugar experience—taste, texture, browning, mouthfeel—with demonstrably smoother metabolic behavior.

Supercrose® was engineered for people who want to enjoy food and protect their metabolic health. And for many, the biggest hesitation comes down to one question:

“If Supercrose contains glucose, won’t it spike my blood sugar?”

The answer—supported by multiple studies—is no. And here’s why.

Allulose + Glucose Behave Differently When Consumed Together

Allulose actively reduces the glycemic impact of co-ingested carbohydrates—including glucose.

Key findings:

• Allulose delays glucose absorption in the small intestine.
• Allulose improves post-meal insulin response.
• Allulose activates GLP-1 pathways naturally.
• Co-ingestion of Allulose and glucose produces a flatter glycemic curve than glucose alone.

Why Supercrose Works So Well in Baking + Cooking

Most alternative sweeteners fail in recipes. Supercrose® succeeds because it uses real sugar chemistry.

Benefits:

• Caramelizes and browns like real sugar.
• Behaves predictably under heat.
• Creates real texture and moisture retention.
• Dissolves smoothly.
• Sweetness matches real sucrose closely.

Ideal for Coffee, Tea, Smoothies & Everyday Drinks

Supercrose® dissolves instantly and tastes identical to sugar, even in cold beverages.

Advantages:

• Zero bitterness or aftertaste.
• No cooling effect.
• Supports balanced energy (glucose provides soft quick energy; Allulose blunts spikes).
• Reduced glucose excursions in beverage applications.

Why Glucose Is NOT the Enemy Here

Table sugar contains fructose—the actual metabolic problem molecule.

Supercrose® has:

• No fructose
• Glucose for functionality
• Allulose for metabolic balance

Studies show:

• Allulose reduces the metabolic load of glucose.
• Flatter blood sugar and insulin curves versus sugar.
• No fructose-driven lipogenesis or liver stress.

Perfect for People Worried About Blood Sugar or GLP-1 Medications

Allulose supports metabolic stability while glucose delivers real sugar performance.

Benefits include:

• Reduced glycemic impact vs. sugar
• Better satiety through GLP-1 activation
• No digestive irritation
• Works in all recipes without compromise

Summary: Why Supercrose Is the Future of Sweetness

Supercrose® solves two problems at once:

1) Perfect kitchen performance

2) Clinically supported metabolic advantages

You get:

• Real caramelization
• Real browning
• Real sweetness&
• Lower glycemic response
• Flatter blood sugar curves
• GLP-1 supportive benefits
• No fructose, sugar alcohols, or artificial additives

Built on science. Backed by data. Designed for real food and real metabolic health.

VIDEOS:

Sources

1. Franchi F., Yaranov L., Rollini F. et al. (2021). Effects of D-allulose on glucose tolerance and insulin response: A randomized, double-blind, crossover study. BMJ Open Diabetes Research & Care. https://pubmed.ncbi.nlm.nih.gov/33637605/

2. Tani Y., Izumori K., et al. (2023). Allulose for the attenuation of postprandial blood glucose levels: A mechanistic evaluation. PLOS ONE. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0281150

3. Au-Yeung F., et al. (2023). Comparison of postprandial glycemic and insulinemic responses to sucrose with and without allulose. Food Research International. https://www.sciencedirect.com/science/article/pii/S175646462300169X

4. Daniel H. (2022). Allulose in the human diet: The knowns and the unknowns. British Journal of Nutrition. https://www.cambridge.org/core/journals/british-journal-of-nutrition/article/allulose-in-human-diet-the-knowns-and-the-unknowns/74020152A1262DF4D7942A4DB54B6E37

5. Iwasaki Y., et al. (2018). Oral D-allulose induces GLP-1 release via intestinal sweet taste receptors and vagal activation. Nature Communications. https://www.nature.com/articles/s41467-017-02488-y

6. Cayabyab K.B., et al. (2024). The Metabolic and Endocrine Effects of a 12-Week Allulose Intervention in Adults. PubMed Central (PMC). https://pmc.ncbi.nlm.nih.gov/articles/PMC11207032/